Please use this identifier to cite or link to this item:
Title: Central American and Caribbean consensus document for the optimal management of oral anticoagulation in patients with non-valvular atrial fibrillation endorsed by the Central American and Caribbean Society of Arterial Hypertension and Cardiovascular Prevention
Autores: Wyss, F.
Barrios, V.
Méndez Castillo, Máxima
Ramos, S.
González, Á.
Ortiz, H.
Rodas Díaz, M.
Castillo, G.
Quesada, E.
Franco, C. E.
Ventura, J.
Peralta López, E.
Somoza, F.
Arguello Montealegre, A.
Meneses, D.
Pichel, D.
Valdez, O.
Researchers (UNIBE): Méndez Castillo, Máxima 
Affiliations: Instituto de Medicina Tropical y Salud Global (IMTSAG) 
Research area: Ciencias de la Salud
Keywords: Anticoagulation; Atrial fibrillation; Vitamin K antagonists; Direct oral anticoagulants; Central American and Caribbean; Access
Issue Date: 2024
Publisher: MDPI
Source: Journal of Clinical Medicine, 13(2), 314; 2024
Journal: Journal of Clinical Medicine 
Volume: 13
Issue: 2
Start page: 314
Atrial fibrillation (AF) is the most common arrhythmia in adults. Prevention of the ischaemic risk with oral anticoagulants (OACs) is widely recommended, and current clinical guidelines recommend direct oral anticoagulants (DOACs) as preference therapy for stroke prevention. However, there are currently no clinical practice guidelines or recommendation documents on the optimal management of OACs in patients with AF that specifically address and adapt to the Central American and Caribbean context. The aim of this Delphi-like study is to respond to doubts that may arise in the management of OACs in patients with non-valvular AF in this geographical area. A consensus project was performed on the basis of a systematic review of the literature, a recommended ADOLOPMENT-like approach, and the application of a two-round Delphi survey. In the first round, 31 recommendations were evaluated and 30 reached consensus, of which, 10 unanimously agreed. The study assessed expert opinions in a wide variety of contextualized recommendations for the optimal management of DOACs in patients with non-valvular atrial fibrillation (NVAF). There is a broad consensus on the clinical practice guideline (CPG) statements used related to anticoagulation indication, patient follow-up, anticoagulation therapy complications, COVID-19 management and prevention, and cardiac interventions.
DOI: 10.3390/jcm13020314
Appears in Collections:Publicaciones indexadas en Scopus / Web of Science
Publicaciones del IMTSAG-UNIBE

Files in This Item:
File Description SizeFormat
jcm-13-00314.pdfFull text [open access]784.62 kBAdobe PDFView/Open
Show full item record Recommend this item

Google ScholarTM






This item is licensed under a Creative Commons License Creative Commons